Inventor · disambiguated record
Mark H. Norman
Also filed as: NORMAN MARK · NORMAN MARK H · NORMAN MARK HENRY
51 granted patents·19 pending applications·732 citations·filing 1998–2016
98Inventor score
Top patents by PatentIndex Score
70 records- 0195US7560460B2Substituted piperazines and methods of useAMGEN INC·Filed 2005·Granted Jul 14, 2009·18 cites·9 claims
- 0294US7820665B2Imidazopyridazine inhibitors of PI3 kinase for cancer treatmentAMGEN INC·Filed 2008·Granted Oct 26, 2010·38 cites·9 claims
- 0394US6187777B1Compounds and methods which modulate feeding behavior and related diseasesAMGEN INC·Filed 1999·Granted Feb 13, 2001·134 cites·20 claims
- 0493US9066954B2Fused heterocyclic derivatives and methods of useAMGEN INC·Filed 2013·Granted Jun 30, 2015·22 cites·9 claims
- 0593US6583154B1Compounds and methods which modulate feeding behavior and related diseasesAMGEN INC·Filed 2000·Granted Jun 24, 2003·57 cites·16 claims
- 0692US8524900B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Granted Sep 3, 2013·23 cites·8 claims
- 0792US7928140B2Benzothiazole PI3 kinase modulators for cancer treatmentAMGEN INC·Filed 2008·Granted Apr 19, 2011·32 cites·17 claims
- 0892US7115607B2Substituted piperazinyl amides and methods of useAMGEN INC·Filed 2002·Granted Oct 3, 2006·42 cites·14 claims
- 0991US7579347B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Aug 25, 2009·17 cites·9 claims
- 1091US7429608B2Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2006·Granted Sep 30, 2008·11 cites·15 claims
- 1191US7265138B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2004·Granted Sep 4, 2007·48 cites·12 claims
- 1290US7078424B2N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteresGUILFORD PHARM INC·Filed 2003·Granted Jul 18, 2006·31 cites·7 claims
- 1389US8088794B2Substituted amide derivatives and methods of useKIM TAE-SEONG·Filed 2010·Granted Jan 3, 2012·14 cites·14 claims
- 1488US8362241B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2010·Granted Jan 29, 2013·11 cites·8 claims
- 1586US7687522B2Substituted pyridines and pyrimidines and their use in treatment of cancerAMGEN INC·Filed 2007·Granted Mar 30, 2010·8 cites·3 claims
- 1685US6977264B2Substituted piperidines and methods of useAMGEN INC·Filed 2002·Granted Dec 20, 2005·26 cites·19 claims
- 1785US6822097B1Compounds and methods of usesAMGEN INC·Filed 2003·Granted Nov 23, 2004·23 cites·44 claims
- 1885US6331537B1Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compoundsGUILFORD PHARM INC·Filed 1999·Granted Dec 18, 2001·59 cites·18 claims
- 1984US7053088B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted May 30, 2006·19 cites·22 claims
- 2083US8685983B2Method of treating cancer with substituted amide derivativesKIM TAE-SEONG·Filed 2011·Granted Apr 1, 2014·7 cites·5 claims
- 2183US7915287B2Substituted heterocycles and methods of useAMGEN INC·Filed 2007·Granted Mar 29, 2011·4 cites·21 claims
- 2282US7396831B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 2382US7335672B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 26, 2008·6 cites·12 claims
- 2480US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 2580US7439360B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Oct 21, 2008·3 cites·11 claims
- 2679US7534798B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted May 19, 2009·4 cites·12 claims
- 2778US8026241B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2009·Granted Sep 27, 2011·3 cites·17 claims
- 2878US7544803B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jun 9, 2009·3 cites·4 claims
- 2978US7301022B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2006·Granted Nov 27, 2007·4 cites·11 claims
- 3078US6586467B2Preparation of phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2001·Granted Jul 1, 2003·11 cites·16 claims
- 3177US8729074B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2010·Granted May 20, 2014·5 cites·2 claims
- 3277US7144888B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Dec 5, 2006·9 cites·25 claims
- 3377US7119111B22-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of useAMGEN INC·Filed 2003·Granted Oct 10, 2006·11 cites·24 claims
- 3474US7153883B2Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compoundsGUILFORD PHARM INC·Filed 2001·Granted Dec 26, 2006·6 cites·3 claims
- 3572US7148221B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Dec 12, 2006·1 cites·19 claims
- 3671US7314933B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jan 1, 2008·1 cites·9 claims
- 3770US8415376B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2009·Granted Apr 9, 2013·1 cites·9 claims
- 3869US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 3969US7511044B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Mar 31, 2009·1 cites·5 claims
- 4069US7390907B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2004·Granted Jun 24, 2008·4 cites·15 claims
- 4164US7582761B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Sep 1, 2009·2 cites·20 claims
- 4264US2009264424A1Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2009·Application pending·0 cites
- 4356US2006241151A1Pyrid-2-one derivatives and methods of useAMGEN INC·Filed 2006·Application pending·0 cites
- 4454US7524874B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Apr 28, 2009·0 cites·19 claims
- 4554US7332511B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 19, 2008·0 cites·19 claims
- 4653US8227469B2Vanilloid receptor ligands and their use in treatmentsBALAN CHENERA·Filed 2009·Granted Jul 24, 2012·0 cites·9 claims
- 4752US2007032518A1Compounds and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 4850US7709501B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2006·Granted May 4, 2010·0 cites·10 claims
- 4950US2009082358A1Vanilloid receptor ligands and their use in treatmentsNISHIMURA NOBUKO·Filed 2008·Application pending·0 cites
- 5049US8314087B2Nitrogen-containing heterocyclyl ketones and methods of useALBRECHT BRIAN K·Filed 2008·Granted Nov 20, 2012·0 cites·6 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark H. Norman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →